Mechanisms of Mucosal Th17 Cell Induction By Segmented Filamentous Bacteria
分节丝状细菌诱导粘膜 Th17 细胞的机制
基本信息
- 批准号:9244017
- 负责人:
- 金额:$ 34.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-15 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAdoptive TransferAdverse effectsAffectAntigen PresentationAntigen-Presenting CellsAntigensArthritisAutoimmune ProcessAutoimmunityBacteriaCD27 AntigensCD4 Positive T LymphocytesCell CountCell Differentiation processCell LineageCellsChronicColitisCollectionCommunitiesDendritic CellsDiabetes MellitusDiphtheria ToxinDiseaseEffector CellEnvironmentEpithelial CellsGenerationsGeneticGenetic ModelsHelper-Inducer T-LymphocyteHomeostasisHybridomasITGAM geneITGAX geneImmuneImmune responseImmunityIn VitroIncubatedIndividualInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInterleukin-17Interleukin-2Interleukin-6IntestinesLaboratoriesLamina PropriaLoxP-flanked alleleLymphoid CellMammalsMediatingModelingMolecularMusPathogenesisPathogenicityPlayProductionRegulationReporterReportingResearch DesignRoleSamplingSpecificityStaining methodStainsSymbiosisSystemT cell differentiationT cell responseT-Cell ActivationT-LymphocyteTestingTimeTransgenic MiceTransgenic Organismscell typecommensal microbescytokineexperimental studyin vivointerleukin-22interleukin-23membermicrobial communitymicrobiotapathogenpreventpublic health relevanceresponsetherapy developmentvillin
项目摘要
DESCRIPTION (provided by applicant): In this proposal we will investigate the mechanisms by which an individual commensal bacterial species induces generation of a specific effector CD4 T cell subset in the intestinal lamina propria. Commensal bacteria represent a diverse microbial community that permanently resides in the intestines of all mammals. As a community, commensals are known to affect multiple aspects of host immunity. Perturbations in the composition of this community are important determinants of disease pathogenesis in many autoimmune conditions, e.g. inflammatory bowel diseases (IBD), diabetes, arthritis. However, how individual microbiota members modulate host immunity in order to provide protection or exacerbate disease is unclear, which has impeded identification of participating molecular mechanisms. We identified a commensal, segmented filamentous bacteria (SFB), that can specifically induce Th17 cells in the gut. Th17 cells are pro-inflammatory cells that play important protective roles against bacterial and fungal pathogens while at the same time contribute to autoimmunity, including IBD and colitis, in susceptible hosts. We showed that presence of SFB in mice specifically induces Th17 cells and leads to increase in mucosal protection against intestinal infections and exacerbation of autoimmunity. Presently, SFB are the only known commensal that induces Th17 cells. We propose to identify host cells responsible for detecting SFB and presenting antigens in order to induce Th17 cells. We will examine the role of intestinal dendritic cells (iDCs), which have been implicated in gut Th17 cell induction. We have discovered that genetic ablation of one iDC subset, the CD103+CD11b+ DCs, leads to a decrease in Th17 cells. We will examine whether CD103+CD11b+ DCs are required for SFB-mediated effects in the gut. We will also examine if SFB antigens are directly sampled to induce SFB-specific Th17 cells. We will utilize a collection of genetic models that we have re- derived SFB-free and Th17 cell-free. This will allow us to colonize these models with SFB and assess the role of the corresponding mechanisms specifically in SFB-mediated Th17 cell induction. Understanding the mechanisms by which commensals modulate T cell homeostasis, and in particular Th17 cell induction will allow for the development of therapies to mimic or antagonize such mechanisms for the directional regulation of inflammatory T cell responses for the boost of mucosal protection in the case of intestinal infections or the decrease in inflammation in the case of IBD.
描述(由申请人提供):在本提案中,我们将研究单个肠道细菌物种诱导肠固有层中特异性效应CD4 T细胞亚群产生的机制。共生细菌代表了永久存在于所有哺乳动物肠道中的多样化微生物群落。作为一个社区,已知寄生虫影响宿主免疫的多个方面。在许多自身免疫性疾病中,该群落组成的扰动是疾病发病机制的重要决定因素,例如炎症性肠病(IBD)、糖尿病、关节炎。然而,个体微生物群成员如何调节宿主免疫力以提供保护或加剧疾病尚不清楚,这阻碍了参与分子机制的鉴定。 我们鉴定了一种可特异性诱导肠道中Th17细胞的杆状、分节丝状细菌(SFB)。Th17细胞是促炎细胞,其在抵抗细菌和真菌病原体方面发挥重要的保护作用,同时在易感宿主中促进自身免疫,包括IBD和结肠炎。我们发现,SFB在小鼠中的存在下特异性诱导Th17细胞,并导致增加对肠道感染和自身免疫恶化的粘膜保护。目前,SFB是唯一已知的诱导Th17细胞的药物。 我们建议鉴定负责检测SFB和呈递抗原的宿主细胞,以诱导Th17细胞。我们将研究肠道树突状细胞(iDCs)的作用,这与肠道Th17细胞诱导有关。我们已经发现,一种iDC亚群(CD103+CD11b+ DC)的基因消融导致Th17细胞的减少。我们将研究是否需要CD103+CD11b+ DCs的SFB介导的影响在肠道。我们还将检查是否直接采样SFB抗原以诱导SFB特异性Th17细胞。我们将利用我们重新衍生的无SFB和无Th17细胞的遗传模型的集合。这将使我们能够用SFB定殖这些模型,并评估相应机制在SFB介导的Th17细胞诱导中的作用。了解免疫调节T细胞稳态的机制,特别是Th17细胞诱导,将允许开发模拟或拮抗这种机制的疗法,用于定向调节炎性T细胞应答,以在肠道感染的情况下增强粘膜保护或在IBD的情况下减少炎症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ivaylo Ivanov Ivanov其他文献
Ivaylo Ivanov Ivanov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ivaylo Ivanov Ivanov', 18)}}的其他基金
Maintenance of mucosal homeostasis by commensal Th17 cells
共生 Th17 细胞维持粘膜稳态
- 批准号:
10621283 - 财政年份:2021
- 资助金额:
$ 34.75万 - 项目类别:
Maintenance of mucosal homeostasis by commensal Th17 cells
共生 Th17 细胞维持粘膜稳态
- 批准号:
10282976 - 财政年份:2021
- 资助金额:
$ 34.75万 - 项目类别:
Maintenance of mucosal homeostasis by commensal Th17 cells
共生 Th17 细胞维持粘膜稳态
- 批准号:
10462753 - 财政年份:2021
- 资助金额:
$ 34.75万 - 项目类别:
Non-redundant functions of type 3 innate lymphoid cells in mucosal immunity
3型先天淋巴细胞在粘膜免疫中的非冗余功能
- 批准号:
9902326 - 财政年份:2019
- 资助金额:
$ 34.75万 - 项目类别:
Discovery of immunomodulatory gut microbes with MAGIC
利用 MAGIC 发现免疫调节肠道微生物
- 批准号:
9808632 - 财政年份:2019
- 资助金额:
$ 34.75万 - 项目类别:
Non-redundant functions of type 3 innate lymphoid cells in mucosal immunity
3型先天淋巴细胞在粘膜免疫中的非冗余功能
- 批准号:
10374839 - 财政年份:2019
- 资助金额:
$ 34.75万 - 项目类别:
New mechanism of commensal bacteria interaction with host immunity
共生菌与宿主免疫相互作用的新机制
- 批准号:
9317868 - 财政年份:2017
- 资助金额:
$ 34.75万 - 项目类别:
Mechanisms of Mucosal Th17 Cell Induction By Segmented Filamentous Bacteria
分节丝状细菌诱导粘膜 Th17 细胞的机制
- 批准号:
8819130 - 财政年份:2013
- 资助金额:
$ 34.75万 - 项目类别:
Mechanisms of Mucosal Th17 Cell Induction By Segmented Filamentous Bacteria
分节丝状细菌诱导粘膜 Th17 细胞的机制
- 批准号:
10475627 - 财政年份:2013
- 资助金额:
$ 34.75万 - 项目类别:
Mechanisms of Mucosal Th17 Cell Induction By Segmented Filamentous Bacteria
分节丝状细菌诱导粘膜 Th17 细胞的机制
- 批准号:
8650824 - 财政年份:2013
- 资助金额:
$ 34.75万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 34.75万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 34.75万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 34.75万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 34.75万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 34.75万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 34.75万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 34.75万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 34.75万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 34.75万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 34.75万 - 项目类别:














{{item.name}}会员




